C. Max Schmidt

21.7k total citations · 2 hit papers
250 papers, 10.1k citations indexed

About

C. Max Schmidt is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Max Schmidt has authored 250 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 172 papers in Oncology, 162 papers in Surgery and 52 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Max Schmidt's work include Pancreatic and Hepatic Oncology Research (160 papers), Pancreatitis Pathology and Treatment (109 papers) and Gallbladder and Bile Duct Disorders (37 papers). C. Max Schmidt is often cited by papers focused on Pancreatic and Hepatic Oncology Research (160 papers), Pancreatitis Pathology and Treatment (109 papers) and Gallbladder and Bile Duct Disorders (37 papers). C. Max Schmidt collaborates with scholars based in United States, Germany and France. C. Max Schmidt's co-authors include Keith D. Lillemoe, Nicholas J. Zyromski, Attila Nakeeb, Michele Yip-Schneider, Martha B. Pitman, Henry A. Pitt, John M. DeWitt, Michael G. House, Christopher L. Wolfgang and Howard Thomas and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

C. Max Schmidt

237 papers receiving 9.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas

2012 1.5k citations Martha B. Pitman, C. Max Schmidt et al. profile →
Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development

2011 562 citations Jian Wu, Hanno Matthaei et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Max Schmidt United States	47	7.6k	6.3k	2.3k	2.3k	1.6k	250	10.1k
Koji Yamaguchi Japan	53	6.1k 0.8×	6.5k 1.0×	2.9k 1.2×	2.1k 0.9×	2.2k 1.4×	484	11.9k
Deborah Stocken United Kingdom	37	5.2k 0.7×	3.2k 0.5×	2.0k 0.9×	3.3k 1.4×	1.0k 0.6×	118	9.4k
Jordan M. Winter United States	46	7.2k 1.0×	5.2k 0.8×	3.5k 1.5×	1.5k 0.7×	3.0k 1.9×	218	11.2k
Alexis Ulrich Germany	45	5.5k 0.7×	4.5k 0.7×	2.1k 0.9×	806 0.4×	1.3k 0.8×	241	8.6k
Olivier Soubrane France	56	4.2k 0.6×	6.7k 1.1×	2.8k 1.2×	2.8k 1.2×	1.6k 1.0×	373	12.5k
Marina Talamonti United States	46	4.8k 0.6×	2.6k 0.4×	2.0k 0.9×	1.0k 0.5×	1.2k 0.8×	208	8.3k
David J. Bentrem United States	45	5.3k 0.7×	2.8k 0.4×	2.0k 0.9×	893 0.4×	1.4k 0.9×	129	7.5k
Junji Furuse Japan	54	6.6k 0.9×	4.7k 0.7×	3.7k 1.6×	2.9k 1.3×	2.2k 1.4×	421	12.7k
Nipun B. Merchant United States	48	5.0k 0.7×	2.1k 0.3×	2.0k 0.8×	1.1k 0.5×	1.7k 1.1×	212	7.7k
Yee Chao Taiwan	47	4.6k 0.6×	2.6k 0.4×	3.9k 1.7×	2.0k 0.9×	2.2k 1.4×	344	11.2k

Countries citing papers authored by C. Max Schmidt

Since Specialization

Citations

This map shows the geographic impact of C. Max Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Max Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Max Schmidt more than expected).

Fields of papers citing papers by C. Max Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Max Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Max Schmidt. The network helps show where C. Max Schmidt may publish in the future.

Co-authorship network of co-authors of C. Max Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of C. Max Schmidt. A scholar is included among the top collaborators of C. Max Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Max Schmidt. C. Max Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mosley, Amber L., Ehsan Irajizad, Michele Yip-Schneider, et al.. (2025). Cyst fluid proteins stratify malignant risk of intraductal papillary mucinous neoplasm of the pancreas. Cancer Letters. 624. 217753–217753.

Chen, Yihui, Rongzhang Dou, Ehsan Irajizad, et al.. (2025). Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyamine Metabolism as a Biomarker of Progression. Clinical Cancer Research. 31(12). 2454–2465.

Sans, Marta, Yuki Makino, Jimin Min, et al.. (2023). Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential. Cancer Discovery. 13(8). 1844–1861. 27 indexed citations

Schmidt, C. Max, et al.. (2022). D²Conv3D: Dynamic Dilated Convolutions for Object Segmentation in Videos. 2022 IEEE/CVF Winter Conference on Applications of Computer Vision (WACV). 1929–1938. 17 indexed citations

Narasimhan, Ashok, Xiaoling Zhong, Eugene P. Ceppa, et al.. (2021). Profiling of Adipose and Skeletal Muscle in Human Pancreatic Cancer Cachexia Reveals Distinct Gene Profiles with Convergent Pathways. Cancers. 13(8). 1975–1975. 18 indexed citations

Yip-Schneider, Michele, Rachel E. Simpson, Cameron L. Colgate, et al.. (2020). A Quantitative Global Proteomics Approach Identifies Candidate Urinary Biomarkers That Correlate With Intraductal Papillary Mucinous Neoplasm Dysplasia. Pancreas. 49(8). 1044–1051. 3 indexed citations

Yip-Schneider, Michele, et al.. (2020). Insurance Type and Marital Status Impact Hospital Length of Stay After Pancreatoduodenectomy. Journal of Surgical Research. 257. 587–592. 6 indexed citations

Schmidt, C. Max, et al.. (2020). Urologic Surgery and COVID-19: How the Pandemic Is Changing the Way We Operate. Journal of Endourology. 34(5). 541–549. 34 indexed citations

Maatman, Thomas K., Daniel Weber, Eugene P. Ceppa, et al.. (2019). Does the Microbiology of Bactibilia Drive Postoperative Complications After Pancreatoduodenectomy?. Journal of Gastrointestinal Surgery. 24(11). 2544–2550. 19 indexed citations

10.

Simpson, Rachel E., Cameron L. Colgate, Eugene P. Ceppa, et al.. (2019). Two open whipples a day: Excessive or efficient. The American Journal of Surgery. 219(3). 390–393. 4 indexed citations

11.

Simpson, Rachel E., Michael G. House, Nicholas J. Zyromski, et al.. (2018). Travel distance affects rates and reasons for inpatient visits after pancreatectomy. HPB. 21(7). 818–826. 10 indexed citations

12.

Sharib, Jeremy, Dana A. Dominguez, Nilotpal Roy, et al.. (2017). Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts. Clinical Cancer Research. 23(16). 4865–4874. 31 indexed citations

13.

Villafañe-Ferriol, Nicole, Amy L. McElhany, Nader N. Massarweh, et al.. (2017). Sequential drain amylase to guide drain removal following pancreatectomy. HPB. 19. S59–S60. 1 indexed citations

14.

Villafañe-Ferriol, Nicole, Amy L. McElhany, Eric J. Silberfein, et al.. (2017). Evidence vs practice in early drain removal following pancreatectomy. HPB. 19. S35–S35. 1 indexed citations

15.

Roch, Alexandra M., John R. Schneider, William P. Lancaster, et al.. (2017). Are BRCA2 gene mutation patients inappropriately under-screened for pancreatic adenocarcinoma?. HPB. 19. S9–S10.

16.

Kadayıfçı, Abdurrahman, Mohammad Al‐Haddad, John M. DeWitt, et al.. (2016). The value of KRAS mutation testing with CEA for the diagnosis of pancreatic mucinous cysts. PMC. 1 indexed citations

17.

Carr, Rosalie A., Alexandra M. Roch, C. Max Schmidt, et al.. (2016). Smoking and IPMN malignant progression. The American Journal of Surgery. 213(3). 494–497. 20 indexed citations

18.

Wu, Jian, Hanno Matthaei, Anirban Maitra, et al.. (2011). Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development. Science Translational Medicine. 3(92). 92ra66–92ra66. 562 indexed citations breakdown →

19.

Yip-Schneider, Michele, Huangbing Wu, S. K. Hekmatyar, et al.. (2009). Targeting mitogen‐activated protein kinase kinase with the inhibitor PD0325901 decreases hepatocellular carcinoma growth in vitro and in mouse model systems†. Hepatology. 51(4). 1218–1225. 28 indexed citations

20.

Klein, Patrick, C. Max Schmidt, Chad Wiesenauer, et al.. (2006). The Effects of a Novel MEK Inhibitor PD184161 on MEK-ERK Signaling and Growth in Human Liver Cancer. Neoplasia. 8(1). 1–8. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact